Effect of discontinuation of lemborexant following long‐term treatment of insomnia disorder: Secondary analysis of a randomized clinical trial

• Egile Nagusiak: Yoshikazu Takaesu (Egilea), Masahiro Suzuki (Egilea), Margaret Moline (Egilea), Kate Pinner (Egilea), Kanako Inabe (Egilea), Yurie Nishi (Egilea), Kenichi Kuriyama (Egilea)
• Formatua: Liburua
• Argitaratua: Wiley, 2023-04-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Discontinuing long‐term pharmacotherapy for insomnia can result in rebound insomnia or withdrawal symptoms and suboptimal treatment. Post hoc analyses evaluated rebound insomnia and withdrawal symptoms among the subset of subjects from a phase III, 12‐month, global, multicenter, randomized,...